<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=Protonitazene</id>
	<title>Protonitazene - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=Protonitazene"/>
	<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=Protonitazene&amp;action=history"/>
	<updated>2026-04-22T03:58:25Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.com/index.php?title=Protonitazene&amp;diff=5369560&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=Protonitazene&amp;diff=5369560&amp;oldid=prev"/>
		<updated>2024-03-06T06:49:30Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:Protonitazene.svg|thumb|{{PAGENAME}}]]&amp;lt;br&amp;gt;&amp;#039;&amp;#039;&amp;#039;Protonitazene&amp;#039;&amp;#039;&amp;#039; is a potent [[opioid]] analgesic drug that is related to [[etorphine]]. It was first discovered in the 1960s by a team of Swiss researchers. Protonitazene is a member of the [[benzimidazole]] class of opioids and is most closely related to other benzimidazoles such as [[clonitazene]] and [[etazene]].&lt;br /&gt;
&lt;br /&gt;
==Chemistry==&lt;br /&gt;
&lt;br /&gt;
Protonitazene is a benzimidazole derivative and is structurally related to other opioid analgesics such as etorphine and clonitazene. The chemical structure of protonitazene consists of a benzimidazole core, with a phenethyl substituent at the 1-position and a propionitazene group at the 2-position.&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
&lt;br /&gt;
As an opioid, protonitazene acts on the [[mu-opioid receptor]] in the central nervous system to produce its analgesic effects. It is a potent agonist at this receptor, with a higher affinity for the mu-opioid receptor than morphine. The exact mechanism of action of protonitazene is not fully understood, but it is believed to involve inhibition of the reuptake of certain neurotransmitters, including [[dopamine]] and [[norepinephrine]], which can result in feelings of euphoria and pain relief.&lt;br /&gt;
&lt;br /&gt;
==Effects==&lt;br /&gt;
&lt;br /&gt;
The effects of protonitazene are similar to those of other opioids and can include pain relief, sedation, and euphoria. However, protonitazene is significantly more potent than morphine, and as such, the risk of overdose and other adverse effects is higher. These can include respiratory depression, nausea, constipation, and dependence.&lt;br /&gt;
&lt;br /&gt;
==Legal Status==&lt;br /&gt;
&lt;br /&gt;
Protonitazene is a controlled substance in many countries, including the United States, where it is classified as a Schedule I drug under the [[Controlled Substances Act]]. This means that it has a high potential for abuse and no accepted medical use.&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
&lt;br /&gt;
* [[Opioid]]&lt;br /&gt;
* [[Benzimidazole]]&lt;br /&gt;
* [[Etorphine]]&lt;br /&gt;
* [[Clonitazene]]&lt;br /&gt;
* [[Etazene]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Opioids]]&lt;br /&gt;
[[Category:Benzimidazoles]]&lt;br /&gt;
[[Category:Analgesics]]&lt;br /&gt;
{{Opioid-stub}}&lt;br /&gt;
{{Pharmacology-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>